AI-Assisted Claims Tagging in Promotional Content Libraries
Regulators now penalize unsubstantiated AI marketing claims with rising enforcement and fines.
Priya Nambiar
Senior Writer
Priya Nambiar
Priya Nambiar covers modular content and claims management, mlr and promotional review and features for The Promo Review.
5 stories
Core Claims Matrix Development for New Drug Approvals
Structured claims mapping helps pharma avoid regulatory trouble at launch.
Priya Nambiar
FDA Draft Guidance on Directional Risk Information in Promotional Labeling
Sixteen-year-old draft rules now guide how FDA polices drug risk disclosures.
Priya Nambiar
Annotated Promotional Piece Requirements for MLR Submissions
Every claim in a drug ad must trace back to documented sources before FDA review.
Priya Nambiar
Modular content in pharma marketing: what breaks when you try to reuse approved claims across channels
Modular content only works if you account for how channels change what claims actually mean.
Priya Nambiar